Search Results - Obesity

2 Results

Sort By:

PEGylated Bilirubin for the treatment of Hyperlipidemia, Obesity, and Type II Diabetes

Project ID: D2018-40Background:Obesity, a low-grade inflammatory disease, has affected more than 150 million people in the US. Obesity and its associated risk factors are a prelude to the development of type II diabetes that accounts for a vast majority of the 25.8 million diabetes cases in the US. Bilirubin, a yellow pigment produced during red blood...

“Thin” Molecules for Treating Obesity and Type II Diabetes

Project ID: D2016-29IP Status: PCT patent application filedInvention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • Bilirubin reduces body fat percentage...